Back to Blog
Press Coverage•

Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation

CEO Diederik van der Reijt discusses Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.

The Boss Magazine

External Publication

Read Original Article
Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation

Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation

This article from The Boss Magazine features CEO Diederik van der Reijt discussing Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.

The piece explores our leadership approach and strategic direction in the longevity medicine space.

Read the full article on The Boss Magazine

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.